Irvine, Calif.-based Masimo Corp. has stuck with its lawyers at Knobbe, Martens, Olson & Bear for more than two decades as it has grown from a tiny startup to a global medical technology company with more than $500 million in annual revenues. On Wednesday, Knobbe Martens partner Joseph Re showed Masimo that the company’s still in good hands, winning a major verdict against one of the few holdouts that has refused to license its patents.
A federal jury in Wilmington, Del., determined that Philips Electronics SA should pay $466.8 million for infringing two Masimo patents on technology for monitoring blood-oxygen levels. Philips made five different arguments for why the patents are invalid, all of which were rejected by the jury.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
